Price T Rowe Associates Inc Pardes Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.14 - $3.7 $1.14 Million - $1.97 Million	-532,729 Reduced 41.41%	753,595 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$2.84 - $8.57 $1.51 Million - $4.54 Million	-530,235 Reduced 29.19%	1,286,324 $3.95 Million
Q1 2022 May 16, 2022	SELL	$5.64 - $15.64 $7.87 Million - $21.8 Million	-1,395,916 Reduced 43.45%	1,816,559 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $31.5 Million - $54.7 Million	3,212,475 New	3,212,475 $52.1 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.